IRCT20161023030452N2已完成3 期
Evaluation of the effects of Escitalopram and Doxepin on improving anxiety and depression and quality of life in patients with chronic obstructive pulmonary disease (COPD)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 40 years
- •Having any class of COPD with any severity
- •Having symptoms of depression and anxiety
- •Patients with stable COPD so that their disease status does not change from day to day and are under constant treatment and there is no change in the type of treatment
排除标准
- •Those whose illness has worsened recently (one week from the start of the study) or while studying
- •Patients with severe dementia, severe cognitive impairment, end-stage cancer, and mental illness, including schizophrenia, suicidal ideation, and more
- •Patients who have recently (two weeks after the start of the study) taken monoamine oxidase inhibitors or those who are taking these medications
- •Patients whose ECG shows long QT intervals
- •Pregnant or lactating women
- •Patients with severe liver, kidney, cardiovascular and motor diseases
- •Patients with uncontrollable epilepsy
- •Patients with a history of intolerance to antidepressants
研究者
相似试验
尚未招募
不适用
Effect of antidepressant drug desvenlafaxine on anxiety and plasma BDNF level in patients.CTRI/2021/11/038260Dr Chaitali Chindhalore
招募中
3 期
Treatment of depressive symptoms in patients with heart failureDepression.Major depressive disorder, single episode, mildF32.0IRCT20190525043700N5Babol University of Medical Sciences80
已完成
2 期
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
已完成
不适用
Efficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialmajor depressive disorderJPRN-UMIN000011191Department of Psychiatry, Fujita Health University School of Medicine200
招募中
2 期
Efficacy of Escitalopram, Venlafaxine and Buspirone in Irritable Bowel SyndromeIrritable bowel syndrome.Irritable bowel syndromeIRCT20150630022991N10Babol University of Medical Sciences90